Aim of the present investigation is to analyse the amount of muscle trauma in relation to the surgical approach and to the individual postoperative functional recovery. The investigation will compare the MIS (minimally invasive surgery) anterior approach with the MIS anterolateral approach to the hip.
The surgical approach to the hip is reportedly an important factor influencing implant stability and postsurgical muscle functioning. Reviewing the literature, controversial studies towards minimally invasive hip surgery can be found. Currently, none of the approaches can be considered superior, but the trend is towards minimally invasive techniques, as it is generally accepted that muscle trauma and damage of the periarticular structures should be minimized. However, a surgical approach that causes no damage to surrounding muscle is unrealistic. Whether the muscle is stretched, transacted or partially torn, injury will occur. Aim of the present investigation is to analyse the amount of muscle trauma in relation to the surgical approach and to the individual postoperative functional recovery. The investigation will compare the MIS anterior approach with the MIS anterolateral approach to the hip. The investigators questioned, which technique would be the less invasive? Pain and functional performance will be measured using the Harris Hip Score, the Western Ontario McMaster, and the UCLA (University of California) Activity Score. Subject quality-of-life will be determined by evaluation the Short-Form 36 Health Survey. Standard radiographs of the hip are required to be captured before surgery and at 3, 6 and 12 months postoperatively. MRI scans will be performed to evaluate tendon defects, fatty atrophy and changes in the muscle cross-sectional area. Next, the patients will be referred for hip sonography, performed by a radiologist who is experienced in imaging of the musculoskeletal system who will be unaware of the clinical examination results of the patients. Moreover gait analyses will be performed preoperatively, 3 and 12 months after surgery. Pre- and postoperative standard blood tests and specific serum trauma markers will be obtained.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
40
The minimally invasive anterior approach The patient is in supine position. The femoral neck is exposed in the interval between tensor fasciae latae, glutei medius and minimus muscles laterally, and sartorius and rectus femoris muscles medially. After osteotomy of the neck and extraction of the head the acetabulum is reamed to prepare for cup prosthesis. Following peritrochanteric capsulotomy the externally rotated, adducted and elevated femur is broached. The MIS anterolateral approach The MIS anterolateral technique is a modified Watson-Jones Approach. The patient is in supine position. This approach uses the intermuscular plane between the gluteus medius and the tensor fascia latae. After the anterior capsule is excised, a disc of the femoral neck is removed.
Department of Orthopaedics
Vienna, State of Vienna, Austria
RECRUITINGMRI evaluation
Cross-sectional area of gluteus medius and tensor fascia latae muscle (cm2)
Time frame: 12 months after surgery
Harris Hip Score
Points (0-100)
Time frame: 12 months after surgery
Tendon defects of the hip abductors (cm) assessed by Ultrasound
Tendon defects of the hip abductors (cm)
Time frame: 12 months after surgery
Gait analysis
posture of the pelvis, hip strength, range of motion
Time frame: 12 months after surgery
Serum trauma marker 1
creatinkinase (u/l)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 2
interleukin-6 (pg/ml)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 3
interleukin-1β (pg/ml)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 4
lactate Dehydrogenase (u/l)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 5
aldolase (u/l)
Time frame: 1 hour preop. to 48 hours postop.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Serum trauma marker 6
Myoglobin (ng/ml)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 7
malondialdehyde (mg/dl)
Time frame: 1 hour preop. to 48 hours postop.
Serum trauma marker 8
glutathione (mg/dl)
Time frame: 1 hour preop. to 48 hours postop.